PMID int64 35.7M 36.4M | Title/Abstract stringlengths 22 8.78k | MeshTerms stringlengths 7 101 | SemanticTypes stringlengths 4 64 |
|---|---|---|---|
36,266,040 | ongo controversi esophag cancer ii gastrectomi versus esophagectomi siewert type ii esophag adenocarcinoma optim manag siewert type ii junction aeg ii adenocarcinoma remain point debat surgic option includ extend total gastrectomi esophagectomi accur identifi locat esophagogastr junction gej import epicent lesion defin refer gej type ii tumor recent iter ajcc describ lesion within cm cephalad cm caudal gej accur stage locat identif nodal metastasi vital guid optim surgic approach endoscopi endosonographi ct pet help guid decis make junction subtyp present extent resect lymphadenectomi remain contest surgic approach remain viabl advantag issu key manag cancer surgeon capabl oper side diaphragm manag oftentim challeng malign | D013274;D004938;D000230 | T191 |
36,266,039 | ongo controversi esophag cancer feed tube pyloroplasti thorac duct clip reduc periop morbid mortal follow esophagectomi remain central surgeon intraop decis make remain wide variat technic approach esophagectomi employ prophylact strategi reduc postop complic articl discuss ongo controversi relat feed tube placement pyloroplasti thorac duct clip evid regard procedur | D013897;D004938 | T023;T191 |
36,266,038 | supercharg jejun interposit complex esophag reconstruct repres high risk challeng procedur dedic pathway multispecialti team facilit systemat checklist approach periop manag evalu long term outcom refin oper techniqu supercharg pedicl jejunum spj long segment interposit esophag reconstruct review articl medic surgic complic among complex nich group patient signific requir care specialist center focus team patient report outcom pros long segment spj interposit recogn provid addit monitor surgic outcom may help guid intervent subsequ symptom control | D004947;D013505 | T061;T023 |
36,266,037 | colon interposit esophag cancer esophagectomi colon interposit adult patient either primari alimentari reconstruct secondari replac initi resectionreconstruct malign benign diseas remain valuabl tool thorac surgeon armamentarium import surgeon remain vers complex oper includ preoper prepar decis make oper procedur technic variat recognit time treatment postop complic articl present technic detail procedur review select publish studi long term result indic outcom revision surgeri | D008874;D004938 | T121;T191;T109 |
36,266,036 | lymph node dissect esophag squamous cell carcinoma lymph node metastasi one import prognost factor esophag squamous cell carcinoma howev optim extent lymph node dissect still debat specif address sever controversi regard lymph node dissect exampl recurr laryng node lymphadenectomi cervic lymphadenectomi thorac duct resect esophag squamous cell carcinoma also describ new concept surgic anatomi upper mediastinum technolog exampl near infrar imag guid lymphat map intraop neural monitor facilit recurr laryng node lymphadenectomi | D000077277;D004938 | T191 |
36,266,035 | endoscop manag esophag cancer esophag cancer eighth common malign worldwid new case diagnos annual although curat approach earli stage esophag cancer histor surgic advanc endoscop techniqu result identif patient may benefit minim invas endoscop therapi exposit discuss identif patient candid endoscop resect detail differ aspect endoscop curat techniqu esophag neoplasia also discuss therapi direct palliat esophag cancer sequela | D000069916;D004938 | T061;T191 |
36,266,034 | immun checkpoint blockad target therapi esophag cancer advanc esophag cancer one lowest year surviv rate histor treatment option limit cytotox chemotherapi recent trial establish key role immun checkpoint inhibitor chemotherapi plus nivolumab pembrolizumab repres new standard care frontlin regimen esophag adenocarcinoma squamous cell carcinoma advanc target molecular target also expand therapeut landscap articl aim provid overview recent advanc immunotherapi target therapi esophag cancer well summar ongo clinic trial futur direct | D000082082;D004938 | T129;T121;T191;T043 |
36,266,033 | adjuv therapi esophag cancer esophag cancer sixth common caus cancer mortal worldwid consid major worldwid health challeng patient diagnos esophag cancer requir extens workup manag strategi multipl clinic trial conduct evalu role chemotherapi chemoradiotherapi recent immunotherapi surgeri set local esophag cancer trimod approach includ preoper chemoradi follow surgeri periop chemotherapi wide accept treat local esophag cancer howev addit immunotherapi current trimod approach produc advantag diseas free surviv review focus exist data adjuv therapi local advanc esophag gastroesophag adenocarcinoma squamous cell carcinoma | D004938;D000230;D002294 | T191 |
36,266,032 | neoadjuv therapi esophag cancer local advanc esophag cancer dismal prognosi surgeri remain cornerston treatment year surviv rate approxim rate local failur distant metastas high follow surgic resect local advanc tumor neoadjuv therapi either radiat therapi chemotherapi combin prior surgeri carri advantag tackl micrometastas improv complet resect rate neoadjuv concurr chemotherapi radiotherapi favor approach evid improv patholog complet respons pcr rate improv surviv compar surgeri alon random trial optim neoadjuv approach ongo | D020360;D004938 | T061;T191 |
36,266,031 | esophag cancer stage accur stage imper manag esophag cancer year differ treatment modal evolv rang endoscop resect tradit surgic resect multimod approach includ addit chemotherapi without radiat articl discuss differ stage group guid clinician determin stage esophag cancer subsequ guidanc appropri treatment modal patient group base tumor node metastasi tnm stage recent refin clinic tnm patholog tnm post neoadjuv yptnm | D004938 | T191 |
36,266,030 | esophag cancer genet clinic translat comprehens genom profil advanc understand molecular basi esophag cancer mark genom heterogen individu patient major histolog subtyp esophag cancer like contribut poor surviv lack univers effect therapi esophag adenocarcinoma squamous cell carcinoma molecular biolog distinct entiti uniqu risk factor geograph distribut may benefit individu treatment strategi molecular character tumor enabl person care provid prognost inform identifi like benefit target therapi andor immunotherapi | D004938;D000230;D002294 | T191 |
36,266,029 | barrett esophagus esophag adenocarcinoma histopatholog perspect esophag adenocarcinoma eac increas preval barrett esophagus long recogn putat precursor lesion eac much still unknown regard cell origin molecular factor influenc neoplast progress accur patholog assess biopsi import identifi patient risk progress eac wherea patholog assess eac specimen play major role influenc therapeut decis make | D001471;D004938;D000230 | T047;T191 |
36,266,008 | sex differ outcom tetralog fallot patient implant cardiovert defibril women congenit heart diseas high risk sudden cardiac death poor studi thus far | D017147;D013771;D006330 | T019;T074 |
36,266,006 | last entrain sequenc novel diagnost techniqu atrial tachycardia mimick supraventricular tachycardia adenosin sensit entrant atrial tachycardia origin near atrioventricular av node av annulus resembl supraventricular tachycardia svts differenti diagnosi sometim challeng | D013617;D054139 | T047 |
36,266,004 | lipomat metaplasia enabl ventricular tachycardia reduc current loss within protect corridor post myocardi infarct ventricular tachycardia vt due entri surviv conduct myocardi corridor across infarct tissu howev conduct corridor particip entri | D002921;D017180 | T047;T046 |
36,266,001 | associ devic detect sleep disord breath implant defibril therapi patient heart failur sleep disord breath high preval heart failur hf suggest risk factor malign ventricular arrhythmia respiratori disturb index rdi comput implant cardiovert defibril icd algorithm accur identifi sever sleep apnea | D017147;D006333;D012891 | T047;T074;T046 |
36,265,999 | ventricular arrhythmia substrat distribut relat sympathet innerv nonischem cardiomyopathi patient nonischem cardiomyopathi patient refer cathet ablat ventricular arrhythmia vas typic either inferolater il anterosept ass va substrat locat poorer outcom ass sympathet denerv import determin arrhythmogen relat nonischem fibrosi general differ va substrat unknown | D017180;D009202 | T047;T046 |
36,265,997 | attenu heartbeat evok potenti patient atrial fibril heartbeat evok potenti hep brain respons heartbeat thought reflect cardiac signal central autonom area suggest marker intern bodi awar eg interocept | D001281;D065812 | T047;T046;T041 |
36,265,994 | novel consider surgic manag individu pancreat adenocarcinoma manag local pancreat cancer pc evolv signific last decad move away priorit surgeri primari treatment modal embrac need preoper neoadjuv multimod therapi achiev durabl diseas free control neoadjuv therapi current recommend patient borderlin local advanc pc increas util patient resect diseas well assess oper follow factor consid clinic stage diseas respons neoadjuv therapi patient perform status patient demonstr respons neoadjuv therapi may benefit signific surgic resect | D010190;D000230 | T191 |
36,265,993 | decis make regard periop therapi individu local pancreat adenocarcinoma pancreat cancer fatal malign project emerg second lead caus cancer relat death unit state despit critic advanc surgic strategi radiograph techniqu system therapi treatment modal remain larg unchang past two decad elicit dire need clinic trial improv qualiti life prolong surviv patient popul emerg innov strategi includ novel combin chemotherapi immunotherapi vaccin small compound drug among other avenu investig improv periop outcom local pancreat cancer | D010190;D000230 | T191 |
36,265,992 | germlin test individu pancreat adenocarcinoma novel genet risk factor germlin genet variant implic increas lifetim risk pancreat cancer pdac identifi case clinic featur famili histori poor sensit identifi carrier risk variant genet test germlin variant potenti guid risk assess surveil recommend high risk individu promot prevent earli detect measur furthermor identif novel germlin variant offer import insight pathogenesi may inform precis medicin approach articl review current understand germlin mutat associ pdac risk implic genet test | D010190;D021441;D000230 | T191 |
36,265,991 | screen surveil pancreat adenocarcinoma high risk individu pancreat ductal adenocarcinoma pdac aggress diseas high mortal larg due late stage diagnosi approxim hereditari detect earli stage pdac precursor lesion pancreat surveil program may improv outcom current surveil annual typic endoscop ultrasound andor magnet reson imag | D010190;D000230;D021441 | T191 |
36,265,990 | learn pancreat adenocarcinoma imag imag endoscopi play sever import role diagnosi manag pancreat ductal adenocarcinoma pdac comput tomographi ct endoscop ultrasound play complimentari role initi diagnosi patholog confirm pdac endoscopi also use manag biliari obstruct gastrointestin complic mri fluorodeoxyglucos pet ct typic use problem solv tool complex case neoadjuv chemotherapi surgeri often select base imag find relat vascular involv tumor invas adjac structur posttreat surveil imag use monitor complic local recurr system metastasi | D010190;D000230;D021441 | T191 |
36,265,988 | imag herit thorac aortic diseas herit thorac aortic diseas htad caus mutat gene confer high risk thorac aortic aneurysm dissect syndrom htad associ system manifest includ marfan loey dietz vascular ehler danlo turner syndrom purpos review summar pathophysiolog cardiovascular imag featur manag htad imag play import role screen aortic dilat monitor progress echocardiogram comput tomographi magnet reson imag common use modal base consensus guidelin prophylact aortic replac indic certain threshold diamet reach | D000784;D017545;D001018 | T047;T046 |
36,265,986 | imag challeng chronic dissect chronic aortic dissect compris heterogen group unrepair repair diseas requir lifelong clinic imag surveil ct mri main imag modal longitudin surveil grow interest emerg imag techniqu prognost potenti imag difficulti span technic diagnost challeng uniqu repair aorta specif complic depend type repair review describ exist emerg imag techniqu outlin technic diagnost challeng encount ct mri highlight diagnost pitfal chronic aortic dissect | D000784 | T047;T046 |
36,265,984 | imag advanc chronic thromboembol pulmonari hypertens chronic thromboembol pulmonari hypertens cteph recogn complic pulmonari embol signific morbid mortal left untreat ongo advanc treatment cteph potenti excel outcom patient diagnos treat time fashion although ventil perfus scintigraphi remain critic screen cteph radiolog diagnosi involv multipl modal digit subtract angiographi high qualiti comput tomographi pulmonari angiographi state art imag cteph also includ dual energi comput tomographi lung subtract iodin map magnet reson imag | D006976;D011655;D007455 | T121;T123;T196;T047;T046 |
36,265,983 | cta acut pulmonari embol best practic pulmonari cta common perform studi radiologist role limit simpli produc report process identifi appropri patient benefit studi improv perform radiolog depart requir radiologist involv expertis leadership focus narrat review highlight differ step way improv qualiti assess thromboembol diseas radiologist impact articl provid updat common use recent publish clinic decis tool specif paramet adjust pulmonari cta challeng patient potenti improv radiolog depart | D011655 | T047;T046 |
36,265,978 | influenc rural environment factor asthma object articl review recent literatur implic agricultur factor includ pesticid animallivestock product facil agricultur dust endotoxin biomasscrop burn nutrit factor respiratori health | D001249;D010575 | T131;T047 |
36,265,977 | air pollut effect allergi asthma outdoor air pollut associ exacerb allerg diseas includ asthma allerg rhiniti atop condit increas allerg diseas preval link urban industri econom growth global air pollut well known disrupt epithelium lead specif diseas organ system epitheli line review provid overview health effect air pollut allerg disord specif address may impact epitheli barrier upper lower respiratori tract facilit health effect associ exposur | D000397;D001249;D000393;D065631 | T131;T047;T069;T080 |
36,265,976 | electron cigarett vape allerg asthmat diseas electron nicotin deliveri system end introduc offer altern combust cigarett signific controversi regard sale regul particular youth high risk patient popul deem major public health concern unit state us surgeon general alreadi associ health consequ recent e cig vape product use associ lung injuri evali expos potenti caus life threaten complic public aim educ reader immedi long term health consequ end may provid patient counsel util focus asthmat popul | D000072137;D066300;D001249 | T055;T047;T073 |
36,265,975 | climat chang factor aerobiolog effect clear evid climat chang occur acceler global temperatur sinc mid nineteenth centuri along rise atmospher carbon dioxid level propos one signific consequ climat chang human health could impact aeroallergen evid around globe point longer abund pollen season associ global warm addit studi also suggest increas pollen allergen due air pollut | D057231;D000397 | T070;T069;T080 |
36,265,974 | eosinophil esophag role environment exposur eosinophil esophag eoe chronic non ige immun mediat reaction character eosinophil infiltr lead esophag dysfunct inflamm potenti fibrot remodel although food allergen general consid lead trigger eoe emerg evid suggest modifi environment factor may also play role pathogenesi eoe articl discuss latest data regard role exposom microbiom environment allergen develop ongo inflamm eoe focus last year relev studi | D057765;D005512 | T047;T046 |
36,265,973 | environment exposur impact pediatr asthma within school environ school microenviron well known host mani indoor allergen pollut strong associ school allergen exposur childhood asthma morbid despit advanc therapi asthma continu one common chronic condit among children associ signific morbid health care util product loss asthma preval also disproportion high among children minor communiti review focus environment exposur associ asthma morbid cockroach mous cat dog dust mite fungus air pollut review also discuss recent school base intervent improv allergi morbid among school age children understand multifacet environment factor may contribut asthma pathogenesi necessari help guid potenti school base intervent | D001249;D004781;D012574 | T092;T047;T073;T037 |
36,265,972 | viral infect wheez preschool children wheez common childhood although small percentag children develop asthma child wheez phenotyp asthma predict indic help predict likelihood futur asthma diagnosi viral infect common childhood wheez episod due respiratori syncyti virus rhinovirus mani treatment option exist wheez children includ wheez persist wheez intermitt due viral infect | D001249;D014777 | T047 |
36,265,971 | immunopatholog differ viral infect allerg asthma diseas pathophysiolog asthma develop heterogen although complex interact factor present one individu earli life viral infect shown play major role induct epitheli damag well various innat adapt immun respons cytokin profil result epitheli damag lead th skew adapt immun respons asthma exacerb children half adult relat viral infect also induc epitheli damag acut predomin th inflammatori respons lead acut symptom chronic airway remodel | D006967;D001249;D014777 | T047;T046 |
36,265,970 | ozon develop pediatr asthma atop diseas ozon ubiquit outdoor air pollut may deriv various primari pollut nitrat hydrocarbon volatil organ compound ultraviolet radiat exposur shown negat impact respiratori health common noninfecti environment caus asthma exacerb among children adult effect pediatr respiratori health could due multipl physiolog factor may contribut enhanc exposur seen children compar adult includ differ lung surfac area per unit bodi weight ventil rate reach distal region human lung due low water solubl result either injuri activ airway epitheli cell macrophag multipl epidemiolog studi highlight link exposur air pollut develop asthma review articl specif focus examin impact earli life exposur lung develop lung function risk develop atop diseas includ asthma allerg rhiniti atop dermat among children | D000393;D001249;D010126 | T131;T047;T103 |
36,265,961 | diaphragmat function cardiovascular diseas jacc review topic week addit diaphragm role primari respiratori muscl also play recogn role cardiac function serv pump facilit venous lymph return modul left ventricular afterload hemodynam pericardi pressur well regul autonom tone heart failur hf associ diaphragmat chang ie muscl fiber atrophi weak increas ratio type type ii muscl fiber alter muscl metaboreflex lead diaphragmat dysfunct subsequ symptomat manifest hf herein propos target diaphragm patient hf via inspiratori muscl train devic base stimul provid novel treatment pathway hf review sever potenti mechan therapi target diaphragm benefici hf ie improv preload reserv atrial ventricular synchroni metaboreflex activ reduc pericardi restraint restor diaphragm strength | D002318;D006333 | T047;T046 |
36,265,959 | circul cell cardiovascular risk peopl without hiv infect lower cd cell count peopl hiv infect pwh associ increas cardiovascular diseas cvd risk whether subset cd helper cell link cvd unclear | D015658;D002318 | T047 |
36,265,957 | noninvas physiolog assess cardiac allograft vasculopathi prognost post transplant event cardiac allograft vasculopathi cav caus impair blood flow epicardi coronari arteri microvasculatur lead caus post transplant mortal cav affect heart transplant recipi within year heart transplant | D016027;D003324 | T061;T047 |
36,265,955 | impact periprocedur pulmonari hypertens outcom transcathet aortic valv replac limit data prognost impact periprocedur pulmonari hypertens ph transcathet aortic valv replac tavr | D065467;D001024;D006976 | T061;T047;T046 |
36,265,953 | canadian spontan coronari arteri dissect cohort studi year outcom spontan coronari arteri dissect scad import caus myocardi infarct mi young middl age women | D005352;D009203;D000072658 | T047 |
36,265,942 | low dose vs high dose paclitaxel coat balloon femoropoplit lesion year result compar trial far year data report direct comparison paclitaxel coat balloon pcbs use differ coat technolog | D000800;D062666;D058729;D011078;D002317 | T061;T121;T109;T131;T047;T074 |
36,265,940 | tempor trend practic variat associ outcom ivus use peripher arteri intervent intravascular ultrasound ivus shown limit prospect studi improv procedur outcom patient undergo lower extrem peripher arteri intervent pvi | D058729;D057510 | T061;T047 |
36,265,938 | sex relat differ thrombus burden stemi patient undergo primari percutan coronari intervent women wors prognosi st segment elev myocardi infarct stemi men prognost role thrombus burden tb influenc sex relat differ clinic outcom stemi clear investig | D003328;D062645;D000072657 | T061;T047 |
36,265,936 | differ demograph outcom men women spontan coronari arteri dissect spontan coronari arteri dissect scad increas recogn caus myocardi infarct mi frequent affect women characterist men scad less well describ | D003330;D014652;D005352;D009203 | T019;T047 |
36,265,933 | enhanc diagnosi plaqu eros deep learn patient acut coronari syndrom acut coronari syndrom caus plaqu eros might potenti manag conserv without stent current diagnosi plaqu eros requir expertis optic coher tomograph oct imag interpret addit current deep learn dl approach oct imag interpret base singl frame without integr inform adjac frame | D054058;D000077321;D058226 | T020;T066;T047;T046;T031 |
36,265,932 | posit statement vascular access safeti percutan devic ami complic cardiogen shock unit state frequenc use percutan mechan circulatori support devic acut myocardi infarct complic cardiogen shock increas devic requir larg bore vascular access provid left right biventricular cardiac support frequent urgentemerg circumst signific technic logist variabl exist devic insert care remov cardiac catheter laboratori cardiac intens care unit variabl practic may contribut advers outcom observ center receiv patient cardiogen shock higher risk circulatori insuffici venous stasi bleed arteri hypoperfus posit statement aim describ public health impact bleed vascular complic cardiogen shock highlight knowledg gap vascular safeti provid roadmap regulatori perspect necessari advanc field propos minimum core set process element vascular safeti bundl develop possibl studi design pragmat trial platform evalu structur approach vascular access drive benefit prevent vascular bleed complic practic | D006353;D009203 | T047;T074 |
36,265,914 | thionat aminofluorophthalimid reduc classic marker cellular inflamm lps challeng raw cell herein present synthesi sever fluorin pomalidomid deriv thionat counterpart subsequ biolog evalu classic marker cellular inflamm treatment lps challeng cell effect vari reduct level secret tnf nitrit relat basal amount aren fluorin thioamid margin sporad effect tnf product specif posit fluorin combin subsequ increas carbonyl thionat produc compound demonstr correspond escal anti nitrit activ concurr minim cellular toxic regard compound display rough cell viabil combin drop nitrit product suppli raw cell challeng ngml lps focus famili fluorin isom direct compar analog fluorin isom display compar minim toxic mark less anti nitrit activ versus raw cell challeng ngml lps compound subsequ screen human liver microsom preliminari phase analysi demonstr heighten stabil relat non fluorin counterpart dithiopomalidomid result line expect metabol fortitud provid fluorin sensit pomalidomid posit | D007249;D014409;D013792 | T121;T129;T116;T109;T131;T046 |
36,265,912 | estim econom cost indigen health inequ new zealand retrospect cohort analysi despit signific intern interest econom impact health inequ studi quantifi cost associ unfair prevent ethnicraci health inequ indigen led studi first investig health inequ mori non mori adult new zealand nz estim econom cost associ differ | D000091682 | T080 |
36,265,906 | transcript factor hb express glial cell lineag develop mous spinal cord hb mnx transcript factor describ spinal cord motor neuron mn specif marker critic factor postmitot specif cell date express hb cell type report perform fate map approach examin distribut hb express cell progeni hb lineag cell within embryon adult spinal cord hb cre ai mice found hb lineag cell distribut gradient increas abund throughout rostrocaud spinal cord axi embryon postnat stage furthermor although major hb lineag cell cervic spinal cord level mns caudal level hb lineag cell includ small diamet dorsal horn neuron astrocyt oligodendrocyt peripher nervous system observ similar phenomenon abund hb lineag schwann cell muscl lower bodi versus upper bodi muscl cultur spinal cord progenitor vitro found gliogenesi increas treatment caudal factor fgf b glial tdtomato express increas treatment fgf b gdf togeth observ suggest earli transient express hb spinal cord neural progenitor may induc caudal factor fgf gdf signal furthermor work rais possibl earli hb express may influenc develop spinal cord macroglia schwann cell especi caudal region togeth find highlight import use caution design experi use hb cre mice perform spinal cord mn specif manipul | D014157;D013116 | T123;T023;T116 |
36,265,905 | context bind visual work memori reflect bilater event relat potenti contralater delay activ success retriev specif item visual work memori vwm depend bind item uniqu context recent function magnet reson imag studi vwm manipul memori set homogen identifi import role intrapariet sulcus context bind independ role repres stimulus ident current studi explor whether contralater delay activ cda event relat potenti erp compon deriv posterior electrod track amount inform held vwm might also sensit context bind demand experi human particip perform later delay recognit memori set contain one three five item drawn categori orient homogen differ categori orient color lumin heterogen locat ident memori probe indic item retriev homogen trial place higher context bind demand vwm capac higher heterogen trial erp contralater contra ipsilater ipsi rememb stimuli higher homogen trial differ remov contra ipsi subtract produc cda experi human particip perform later delay recal memori set one three item homogen heterogen behavior superior three item heterogen trial homogen trial model reveal context bind error latter bilater erp cda result replic experi result support cda track number object file engag vwm establish sensit context bind demand | D008570;D014796 | T041 |
36,265,904 | distribut featur potenti effect serotonin cerebrum sod ga transgen mice serotonin ht particip pathogenesi amyotroph later sclerosi al effect complet clarifi therefor observ distribut featur potenti effect ht cerebrum ga sod transgen tg wild type wt mice fluoresc immunohistochemistri western blot elisa well motor function measur ht tryptophan hydroxylas tph main present limbic system cerebrum glomerular layer olfactori bulb nucleus accumben cingul fimbria hippocampus mediodors thalam nucleus habenular nucleus ventromedi hypothalamus nucleus later hypothalamus area dorsal raph nucleus piriform cortex tph ht express cell bodi dorsal raph nucleus piriform cortex region distribut filament clump shape axon tph distribut cerebrum tg signific lower wt preset onset progress stage tph express fimbria hippocampus mediodors thalam nucleus habenular nucleus ventromedi hypothalamus nucleus later hypothalamus area increas onset stage decreas progress stage gradual decreas cingul diseas progress signific decreas glomerular layer olfactori bulb nucleus accumben onset stage tg number mammalian achaet scute homolog subventricular zone svz tg signific lower wt correl tph distribut doubl immunofluoresc stain show tph mammalian achaet scute homolog ht main express neuron rare express microglia astrocyt piriform cortex relat fluoresc densiti tph cingul region negat correl diseas sever find suggest ht play protect role al like regul neural stem cell subventricular zone might involv neuron develop piriform cortex | D000690;D054022 | T047;T023 |
36,265,902 | intrins disord protein region requir cell wall homeostasi bacillus subtili intrins disord protein region idr implic divers nuclear cytoplasm function eukaryot role bacteria less clear report extracytoplasm idr bacillus subtili requir cell wall homeostasi b subtili transcript factor activ respons envelop stress regul intramembran proteolysi rip membran anchor anti factor rsgi unlik canon rip pathway show ectodomain site cleavag rsgi constitut two cleavag product remain stabli associ prevent intramembran site proteolysi regul step pathway dissoci trigger impair cell wall synthesi requir rsgi extracytoplasm idr intrigu major peptidoglycan polymeras pbp also contain extracytoplasm idr show region import function dispar idr replac nativ idr rsgi pbp argu unstructur region function similar data support model rsgi signal system pbp repres complementari pathway repair gap pg meshwork idr rsgi sens gap activ idr pbp direct synthas site fortifi | D001412;D064267 | T123;T007;T116 |
36,265,899 | reduct opioid use orthoped surgeri scope review opioid epidem one biggest public health crise time overprescrib opioid surgeri potenti lead long term use purpos review identifi summar avail evid intervent aim reduc opioid use orthoped surgeri | D019637;D009293 | T061;T048 |
36,265,898 | role skin bridg incis prophylact incision negat pressur wound therapi prevent surgic site infect inguin lymph node dissect modif surgic techniqu incis techniqu skin bridg tradit lazi ls incis well use prophylact incision negat pressur wound therapi inpwt theoriz reduc risk surgic site infect ssi inguin lymph node dissect ilnd sought investig role periop ilnd bundl advers event ilnd lymph node harvest | D054843 | T061;T074 |
36,265,897 | mdf conserv splice factor modul cell divis stress respons arabidopsi coordin cell divis stress respons essenti maintain genom stabil plant meristem protein involv pre mrna splice import process anim human cell base homolog splice factor sart implic control cell divis genom stabil human cell analyz mdf similar function plant found mdf associ uuu tri snrnp protein essenti correct splice transcript loss mdf function lead cell divis defect cell death meristem associ regul stress induc gene regul mitot regul addit mdf mutant hypersensit dna damag treatment support role coordin stress respons cell divis analysi dephosphomut mdf suggest protein activ might control work uncov conserv function plant splice factor provid novel insight interplay pre mrna process genom stabil plant | D017415;D017360 | T123;T116;T002 |
36,265,896 | dlk dio cluster mirna regul mitochondri function dystroph muscl duchenn muscular dystrophi duchenn muscular dystrophi dmd sever muscl diseas caus impair express dystrophin wherea mitochondri dysfunct thought play import role dmd mechan dysfunct remain clarifi demonstr dmd muscular dystrophi larg number dlk dio cluster mirna dd mirna coordin regul regener myofib serum character biolog effect dysregul dd mirna simultan overexpress vivo mous muscl transcriptom analysi reveal high similar chang muscl ectop overexpress dd mirna mdx diaphragm natur regul dd mirna among common dysregul pathway found repress mitochondri metabol oxid phosphoryl oxpho particular knock dd mirna ip deriv skelet myotub result increas oxpho activ data suggest dd mirna import mediat dystroph chang dmd muscl mitochondri metabol oxpho particular target dmd coordin regul dd mirna find provid insight mechan mitochondri dysfunct muscular dystrophi | D035683;D020388 | T123;T047;T114 |
36,265,895 | induc amphipath helix mediat subcellular target membran bind rpe rpe retinol isomeras indispens player visual cycl vertebr retina rpe although membran associ critic rpe function mechan clear residu believ interact membran unresolv rpe crystal structur wherea palmitoyl c also play role report mechan membran recognit bind rpe bind aa synthet peptid membran mimick micellar surfac induc transit unstructur loop amphipath helic ah structur transit automat c palmitoyl peptid demonstr ah signific affect palmitoyl level membran associ isomer activ rpe furthermor aa function membran sensor ah membran target motif molecular dynam simul clear show ah membran insert support experiment find collect studi allow us propos work model rpe membran bind provid novel role cystein palmitoyl | D003545;D005136 | T123;T121;T116 |
36,265,894 | neuroimag pediatr patient juvenil xanthogranuloma cns juvenil xanthogranuloma rare clonal myeloid neoplast disord typic juvenil xanthogranuloma self limit disord infanc often present solitari red brown yellow skin papulenodul small subset patient present extracutan system juvenil xanthogranuloma may includ cns goal retrospect studi evalu categor neuroimag find repres cohort pediatr patient cns juvenil xanthogranuloma | D014972 | T191 |
36,265,892 | delay ctp deriv deep venous outflow novel predictor striatocapsular infarct thrombectomi isol striatocapsular infarct occur common patient ischem stroke follow thrombectomi aim explor correl ctp deriv paramet deep venous outflow present subsequ striatocapsular infarct retrospect cohort patient | D020521;D002545 | T047;T046 |
36,265,891 | schizencephali hereditari hemorrhag telangiectasia presenc malform cortic develop patient hereditari hemorrhag telangiectasia report previous occas evalu sampl adult hereditari hemorrhag telangiectasia presenc malform cortic develop spatial coincid malform cortic develop avm coincid brain pulmonari avm | D013683;D065707;D065706;D001165 | T019;T047 |
36,265,859 | second type n guanin rna cap methyltransferas unusu locus larg rna virus genom order nidoviral divers group rna virus common genom organ conserv set replic edit enzym particular rna methyltransferas play central role mrna stabil immun escap howev presenc distribut differ nidoviral famili homogen coronavirida best character famili two distinct methytransferas perform methyl n guanin oh rna cap generat cap structur mgpppnm gene enzym locat orfb genom region mtase identifi famili base conserv sequenc motif genet loci identif n guanin methyltransferas prove challeng recent identifi putat n mtase domain orfa region n mt certain member larg genom tobanivirida famili demonstr domain inde harbor n specif methyltransferas activ present structur first n specif rossmann fold rf mtase identifi rna virus make remark differ known coronavirida orfb n mtase gene discuss evolutionari implic appear unexpect locat genom introduc split classif tobanivirida | D012315;D028381 | T123;T005;T114 |
36,265,857 | clinic manifest varicella diseas larg forgotten gone year varicella vaccin unit state classic varicella complic becom uncommon occurr clinic manifest varicella among vaccin person usual modifi fewer skin lesion most maculopapular milder present howev potenti sever manifest varicella still exist among vaccin unvaccin person thus healthcar provid keep varicella differenti diagnosi maculopapular vesicular rash prompt recognit diagnosi varicella import confirm clinic public health measur need taken swift | D002644 | T047 |
36,265,856 | impact univers varicella vaccin herp zoster incid unit state comparison birth cohort preced follow varicella vaccin program launch us varicella vaccin program introduc impact epidemiolog herp zoster hz precis known use larg claim databas examin hz incid us among person age year prevaccin cohort born age year includ postvaccin cohort born sinc defin incid hz first instanc outpati emerg depart ed claim hz diagnost code addit examin proport hz visit among ed visit complementari method assess healthcar seek artifact find person age year prevaccin cohort observ age specif increas hz incid earlier studi year deceler later year start oldest age group similar pattern seen examin hz visit proport ed visit person age year age specif hz incid increas earli studi period oldest age group born prevaccin later declin stepwis pattern age group compris person born postvaccin period result corrobor previous publish studi support prior model predict varicella vaccin program would increas hz incid among adult cohort previous experienc varicella find also suggest continu declin age specif hz incid varicella vaccin cohort age like | D002644;D006562 | T047 |
36,265,855 | monitor varicella vaccin impact varicella incid unit state surveil challeng chang epidemiolog surveil critic monitor vaccin impact varicella surveil challeng predat varicella vaccin us licensur sever interim step need case base surveil could establish state activ passiv surveil need document vaccin program impact varicella incid end dose program incid declin activ surveil area signific declin occur age group within year program implement addit declin occur dose program lead declin incid year program implement base data state continu passiv report surveil show declin highest among children adolesc cover routin vaccin recommend occur age group although surveil system chang adapt reflect evolv epidemiolog data consist demonstr decreas varicella incid follow vaccin program implement vaccin program dramat decreas virus circul increas communiti protect continu improv varicella surveil need accur monitor diseas epidemiolog guid prevent effort | D002644;D014765 | T129;T047;T121 |
36,265,854 | merckcent diseas control prevent varicella vaccin pregnanc registri year summari data incept closur varivax pregnanc registri establish monitor pregnanc outcom women receiv varicella vaccin ie varivax inadvert pregnant | D014765;D000073618 | T129;T047;T121 |
36,265,853 | insight studi genet pathogenesi immunogen varicella vaccin varicella vaccin creat approach establish live attenu viral vaccin novel method probe virus host interact use explor genet pathogenesi immunogen vaccin compar wild type varicella zoster virus vzv summar mechan base understand safeti efficaci varicella vaccin achiev investig | D006562;D014765;D053061 | T129;T047;T121 |
36,265,852 | declin sever varicella diseas unit state varicella vaccin program hospit death describ impact us varicella vaccin program sever varicella outcom analyz varicella hospit use nation inpati sampl varicella death use nation center health statist data year vaccin program varicella hospit death declin respect among person age respect among person age year born varicella vaccin program varicella hospit varicella death prevent annual unit state direct result vaccin reduct varicella zoster virus circul | D002644;D006562 | T047 |
36,265,851 | chang epidemiolog varicella outbreak unit state varicella vaccin program describ chang epidemiolog varicella outbreak inform past current activ passiv surveil unit state review data publish analyz new data varicella outbreak defin varicella case within set incub period dose varicella vaccin program number varicella outbreak declin vs activ surveil area vaccin coverag reach dose program state consist report center diseas control prevent number outbreak declin vs entir program outbreak size durat declin median casesoutbreak day durat case day durat proport outbreak case increas outbreak case occur among unvaccin partial vaccin person elig second dose vaccin highlight potenti varicella control | D002644 | T047 |
36,265,850 | diagnost immunolog test varicella era high impact varicella vaccin evolv problem clinic present varicella unvaccin person skin vesicl scab facilit use rapid diagnost method confirm diseas polymeras chain reaction pcr assay diagnost method choic sharp declin unmodifi case varicella due us varicella vaccin program led fewer healthcar provid familiar varicella present increas relianc laboratori diagnosi confirm suspect case mild atyp present diseas vaccin person fewer skin lesion most maculopapular made challeng provid recogn also collect sampl detect virus nonetheless pcr high sensit specif confirm modifi diseas adequ sampl provid posit pcr result confirmatori interpret negat result prove challeng determin whether suspect varicella fals negat attribut caus enhanc educ healthcar provid critic adequ specimen collect modifi varicella case addit sensit commerci serolog assay need unit state varicella immun test vaccin era | D002644 | T047 |
36,265,849 | prevent control nosocomi varicella unit state varicella vaccin program era unit state varicella vaccin program success reduc varicella incid hospit consequ reduc risk nosocomi exposur howev patient healthcar personnel hcp continu introduc varicella zoster virus vzv healthcar set herp zoster hz less contagi varicella also result exposur unrecogn varicella hz may lead extens contact investig control effort hcp furlough result signific disrupt healthcar activ well substanti cost robust occup health infect prevent program ensur healthcar personnel immun prompt recognit isol patient varicella hz lower risk vzv transmiss reduc elimin need furlough expos hcp associ cost | D002644;D003428;D006562 | T047 |
36,265,848 | celebr year varicella vaccin coverag children adolesc unit state success stori track vaccin coverag critic compon monitor vaccin program three differ surveil system use examin trend varicella vaccin coverag unit state vaccin program nation immun survey child nation immun survey teen immun inform system iiss relationship trend school requir diseas declin also examin among children age month dose varicella vaccin increas end dose program stabil around least thereaft uptak second dose rapid recommend two dose coverag among children age year high perform ii site increas among adolesc age year dose coverag increas proport adolesc histori varicella diseas declin state district columbia dc dose daycar school entri requir state dc dose school entri requir school year success attain maintain high vaccin coverag paramount dramat reduct varicella burden unit state year vaccin program opportun remain increas coverag decreas varicella morbid mortal | D002644 | T047 |
36,265,847 | health econom impact unit state varicella vaccin program aim studi evalu health econom impact varicella vaccin program varicella diseas unit state us | D002644;D014612 | T129;T047;T121;T116 |
36,265,846 | safeti surveil varicella vaccin vaccin advers event report system unit state vaccin advers event report system vaer unit state nation passiv vaccin safeti surveil system updat data safeti singl antigen varicella vaccin var assess safeti combin measl mump rubella varicella vaccin mmrv licens unit state use vaer data | D009107;D012409;D008457 | T047 |
36,265,844 | effect varicella vaccin year postlicensur experi unit state summar studi varicella vaccin effect prevent varicella lesson learn first year varicella vaccin program unit state one dose varicella vaccin provid moder protect varicella sever high protect sever varicella wane protect time dose program substanti impact incid varicella sever outcom decreas although prevent low level communiti transmiss outbreak continu occur high vaccin popul two dose varicella vaccin improv vaccin effect least varicella sever declin incid varicella sever outcom well number size outbreak evid wane effect dose vaccin | D002644;D014765 | T129;T047;T121 |
36,265,816 | assess contribut ugt isoform raltegravir drug disposit pbpk model work aim develop physiolog base pharmacokinet pbpk model raltegravir account udp glucuronosyltransferas ugt metabol assess effect ugt gene polymorph raltegravir elimin evalu use k v max valu human recombin system ugt tissu scalar consid liver kidney intestin predictedobserv ratio raltegravir pk paramet within fold error rang ugta poor normal metabol except asian ugta poor metabol pbpk model approach suggest ugta main contributor raltegravir metabol ugta ugta gene polymorph might addit effect raltegravir drug disposit respons final model account hepat renal intestin ugt metabol biliari clearanc renal excret improv model predict compar previous publish model pbpk model quantit character raltegravir elimin pathway support dose adjust differ clinic scenario | D008862;D014453 | T026;T126;T116 |
36,265,815 | develop digit twin tablet mimic real solid dosag form differ dissolut profil convent mini usp ii biorelev colon model perform colon target solid dosag form common assess use standardis pharmacopei dissolut apparatus like usp ii miniaturis replica mini usp ii howev fail replic hydrodynam shear stress colon environ crucial tablet drug releas process work comput simul use creat digit twin dissolut apparatus develop method creat digit twin tablet behav realist model use investig drug releas profil shear rate act tablet differ paddl speed mini usp ii biorelev colon model understand mini usp ii oper achiev realist ie vivo hydrodynam condit behaviour tablet motil pattern use simul deriv experiment vivo data respect obtain profound insight tablet disintegrationdrug releas process recommend oper mode mini usp ii generat shear rate peak would better reflect vivo condit human colon instead constant paddl speed | D057446;D003106 | T023;T070 |
36,265,808 | arylalkylamin n acetyltransferas gene aanat regul cuticl pigment ovari develop adult orient fruit fli bactrocera dorsali arylalkylamin n acetyltransferas aanat enzym catalyz acetyl coa depend acetyl amin arylalkylamin involv import biolog process insect carri molecular biochem ident arylalkylamin n acetyltransferas aanat orient fruit fli bactrocera dorsali use bacteri express system express puri encod recombin bdoraanat v protein puri recombin protein act wide rang substrat includ dopamin tyramin octopamin serotonin methoxytryptamin tryptamin show similar substrat afniti ie k valu mm except serotonin k mm dopamin k mm transcript prole analysi bdoraanat reveal gene preval adult abund adult brain gut ovari use crisprca techniqu success obtain bdoraanat knockout strain base wild type strain wt compar wt cuticl color larva pupa normal howev adult mutant yellow region thorax dark pigment two black spot evid abdomen end moreov femal bdoraanat knockout mutant smaller ovari wt laid far fewer egg loss function bdoraanat caus rnai matur adult femal reproduct system fulli develop effect fecund altogeth result indic bdoraanat regul ovari develop find provid evid insect aanat modul adult cuticl pigment femal fecund | D047068;D033621 | T126;T116;T204 |
36,265,807 | character cuticular protein cpr famili wolf spider pardosa pseudoannulata respons one subfamili gene environment stress cuticular protein cp play essenti role construct function exoskeleton arthropod cpr famili cp reber riddiford r r consensus largest cp famili insect lack systemat research non insect arthropod studi explor cprs wolf spider pardosa pseudoannulata predat mani insect pest total identifi cprs p pseudoannulata genom divid two subgroup base r r consensus sequenc cprs rr rr rr member present novel consensus amino acid g x g x x x g x n e x g common characterist rr cprs chelicer transcriptom data use document express pattern cpr gene differ tissu ecdysi process specif express found part cpr gene five rr gene specif express male genit bulb eleven rr gene high express integu due limit number integu specif express rr gene analyz respons differ environment stress transcript level except papscpr ten rr gene respond least one environment stress among express papscpr signific chang three stress dryness low temperatur imidacloprid treatment silenc papscpr increas toler p pseudoannulata imidacloprid overal result present novel consensus characterist cprs p pseudoannulata help identif evolut analysi cprs non insect arthropod | D013112;D001181;D016887 | T061;T204 |
36,265,793 | general control architectur later prefront cortex cognit control guid non habitu goal direct behavior allow us flexibl adapt ongo demand previous work suggest multipl cognit control process exist class accord action present orientedextern inform versus futur orientedintern inform process map onto later prefront cortex lpfc increas rostral area involv increas futur orientedintern control process whether process organ support goal direct behavior remain unclear one hand lpfc may flexibl adapt base upon demand hand may consist control architectur control hierarchi general across demand previous work use fmri human comprehens control task engag sever control process found area mid lpfc consist exert widespread influenc throughout lpfc data suggest mid lpfc form apex putat control hierarchi howev whether architectur general across task remain test util modifi comprehens control task design alter control process influenc one anoth test generaliz lpfc control architectur univari fmri activ reveal distinct control relat activ relat past work despit chang effect connect model reveal direct architectur similar previous find mid lpfc exert widespread influenc throughout lpfc result suggest fundament control architectur lpfc relat fix differ demand accommod modul fix architectur | D001931;D017397 | T029;T030;T060;T062;T023 |
36,265,789 | effect dissolv oxygen high cn wastewat treatment move bed biofilm reactor base heterotroph nitrif aerob denitrif nitrogen remov perform potenti mechan studi investig nitrogen remov nr perform potenti mechan high cn wastewat treatment differ dissolv oxygen concentr result show concentr signific affect remov effici total nitrogen tn initi increas mgl tn remov effici signific increas howev increas promot tn remov nr initi concentr mgl effect concentr nr influenc combin action function bacteria electron flow excess concentr posit affect nr effici promot electron util respiratori prolifer concentr mgl electron generat sodium acet metabol transfer aerob denitrif process compar concentr mgl | D058465;D018508 | T057;T052;T044;T038 |
36,265,788 | mechan carbon sourc util microalga co cultiv photosynthet bacteria microalga photosynthet bacteria psb co cultur promis wastewat treatment lipid product lack studi work combin microalga psb strain first screen differ inocul ratio co cultur investig found best promot chlorella pyrenoidosarhodobact capsulatus co cultur biomass product acet assimil rate lipid product time sum pure microalga psb cultur respect meanwhil inocul ratio signific affect growth rate lipid product co cultur system itraq analysi show psb play posit effect acet assimil tca cycl glyoxyl cycl microalga decreas carbon dioxid util photosynthesi indic psb promot microalga metabol organ carbon util weaken inorgan carbon util find provid depth understand carbon util microalga psb co cultur | D058086;D002708 | T002;T204 |
36,265,786 | valor biomass gasif green hydrogen generat comprehens review green sustain hydrogen biomass gasif process one promis way altern fossil fuel base hydrogen product first overview green hydrogen generat biomass gasif process present correspond possibl gasif reaction effect respect experiment criteria explain detail addit comprehens explan catalyt effect tar reduct hydrogen generat via catalyt gasif present regard function mechan various type catalyst furthermor commerci aspect associ technic challeng barrier prospect biomass gasif process green hydrogen generat discuss final comprehens review provid relat advanc challeng great insight biomass gasif green hydrogen generat realiz sustain hydrogen societi via biomass valor | D006859 | T196 |
36,265,785 | explor intern drive mechan under bacteri communiti induc organ compon convers humus format rice straw compost tricarboxyl acid cycl regul addit aim studi investig effect tricarboxyl acid tca cycl regul co emiss convers organ compon humus format compost addit adenosin triphosph atp nicotinamid adenin dinucleotid nadh reduc co emiss rice straw compost accord co occurr network result atp enhanc connect complex network nadh enhanc microbi interact differ kind tca cycl regul differ effect humus format pathway structur equat model show atp might promot lignin transform humus via sugar amin condens pathway lignin protein pathway nadh may promot cellulos degrad solubl sugar organ matter transform humus work provid valuabl guidanc explor mechan tca cycl regul promot organ carbon fixat reduc inorgan carbon miner | D000076282;D012275 | T068;T168;T002;T167 |
36,265,784 | solid slow releas carbon sourc improv simultan nitrif denitrif process low carbon resourc wastewat studi acinetobact pittii sp isol high effici heterotroph nitrif aerob denitrif hn ad boundari condit total nitrogen tn remov follow cn ratio temperatur c initi ph shaker speed rpm addit mix carbon resourc achiev ammonia n tn remov higher group sole carbon resourc ammonia n tn remov profil match well first order kinet rapid respons period zero order kinet slow reaction period meanwhil enzym activ relat nitrogen convers would remark increas mix carbon resourc furthermor propos possibl relationship solid carbon sourc hydrolysi solubl small molecul organ matter microbi activ heterotroph nitrif aerob denitrif hn ad studi provid new strategi improv nitrogen remov wastewat low carbon resourc | D058465;D000150 | T007;T044;T038 |
36,265,731 | character dissolv black carbon bind behavior ceftazidim diclofenac pharmaceut employ molecular weight fraction ubiquit compon aquat environ dissolv organ matter dom readili bind residu pharmaceut contamin pcs influenc environment behavior howev bind mechan dissolv black carbon dbc vital part natur dom pool pcs poor research studi bulk dbc divid four fraction molecular weight mw via ultrafiltr system properti dbc bind interact two kind typic pcs ceftazidim caz diclofenac dcf explor concret result show low mw compon main contributor bulk dbc aromat increas increas mw categori chemic structur fluoresc substanc differ mw dbc similar multispectr techniqu show oxygen enrich compound dbc higher affin cazdcf nh cooh nh group caz molecul appear form hydrogen bond dbc fluoresc quench experi analyz bind mechan specif expound thermodynam perspect fluorophor fulvic acid like compound fa quench static dynam quench mechan static quench occur humic acid like compound ha bulk dbc hydrogen bond van der waal forc major forc ha caz system hydrophob forc made primari contribut ha dcf system might ascrib higher hydrophob natur dcf notabl increas ha mw main bind mode ha cazdcf chang hydrophob forc hydrogen bond van der waal forc gradual also direct prove various noncoval interact co driven bind process find benefici better assess fate dbc pcs correspond complex aquat environ | D002442;D004008 | T121;T195;T109 |
36,265,730 | traceabl nitrat pollut hotspot plain river network yangtz river delta nitrogen oxygen isotop coupl bayesian model advers effect increas nitrat pollut especi non point sourc hydrospher anthropospher becom promin non point deriv river suppli upstream threaten aquat ecosystem taihu lake dual stabl isotop n appli bayesian model siar quantit sourc identif reactiv nitrogen nr mix agricultur urban region along complex river network yangz river delta result show concentr river rang mg l decreas high urban area lakesid rural area specif isotop characterist four sourc atmospher deposit ad chemic fertil cf manur sewag ms soil leachat sl siar isotop model indic ms sourc made greatest contribut total load follow sl cf ad high urban area hybrid area contain mix industri popul agricultur area identifi hotspot area heavi nr pollut respons spatial pattern n hotspot area character less well develop sewag pipelin system high nr emiss cash crop chang wastewat treatment level agricultur product structur meteorolog chang main factor spatial variat nr concentr sourc upstream taihu lake basin variat nr concentr across taihu lake would respond anthropogen driven nr load find suggest ms predomin sourc strongest effect overal riverin sourc primari problem need solv | D045483;D014874 | T131;T070 |
36,265,729 | ambient fine particul matter exposur human earli placent inflamm effect fine particul matter pm human earli matern fetal interfac unknown explor associ matern exposur ambient pm inflamm placent villus women clinic recogn earli pregnanc loss crepl women normal earli pregnanc nep tempor adjust land use regress model use estim matern daili pm exposur pregnanc villus interleukin beta il interleukin il tumor necrosi factor alpha tnf measur use multiplex cytokin detect platform singl day lag effect pm exposur within ten day earli placent villus collect estim use multivari linear regress model distribut lag net cumul effect pm exposur within ten day villus collect well five singl week periovulatori period estim use distribut lag non linear model subject adjust group crepl nep tempor confound demograph characterist singl day distribut lag effect pm exposur lag signific increas villus il distribut lag effect pm exposur first second week ovul increas il pm exposur third week ovul increas il tnf crepl singl day lag effect signific increas il lag il lag tnf lag distribut lag effect increas il lag lag tnf lag lag cumul effect within ten day villus collect increas il statist signific cumul effect nep summari matern pm exposur associ placent inflamm human earli pregnanc particular increas villus il crepl whether matern fetal interfac inflamm relat pm exposur periovulatori period later contribut crepl advers pregnanc outcom requir studi | D000397;D000393 | T131;T069;T080 |
36,265,727 | uv stabil foster earli develop biofilm freshwat microplast interact microb microplast import emerg plastic load global environ although divers plastic addit use larg amount studi quantit comparison plastispher plastic differ plastic addit studi effect two wide use uv stabil benzotriazol type uv benzophenon type uv select base persist toxic low densiti polyethylen ldpe freshwat microb first studi sole effect uv stabil use plastic addit freshwat situ plastispher biofilm develop confoc laser scan microscopi assist proper differenti fluorochrom threshold base segment data use visual quantifi biofilm first week biofilm growth littl biovolum neglig amount phototroph pristin ldpe contrast substrat biovolum signific higher ldpe uv stabil higher pristin ldpe although biomass most dead due toxic higher dead biovolum live biovolum ldpe uv stabil fourth week margin higher biovolum along reviv biomass ldpe uv stabil observ abil induc microorganism intracellular reactiv oxygen speci uv stabil detect may stimul biofilm growth primari phase biofilm develop atom forc microscopi analysi denot ldpe uv stabil exhibit consider stronger adhes forc pristin ldpe observ suggest uv stabil foster earli attach microb microplast kill surfac contact layer aliv upper layer microb get develop dead biofilm without much disrupt due toxic uv stabil occurr eventu boost earli develop biofilm plastic | D010969;D000080545 | T122;T167 |
36,265,724 | fluoroquinolon antibiot occurr mode action resist environment detect remedi comprehens review antibiot play essenti role medic healthcar world widespread usag high preval pose negat environment consequ past decad various antibiot drug detect aquat terrestri ecosystem among fluoroquinolon fq group ubiquit environ emerg major environment pollut fqs signific broad spectrum antibiot use treat various pathogen diseas human anim known use fqs ciprofloxacin norfloxacin ofloxacin levofloxacin enrofloxacin danofloxacin moxifloxacin human anim administr drug excret unalt form environ besid wastewat discharg pharmaceut industri hospit agricultur runoff major contributor accumul fqs ecosystem long term presenc environ creat select pressur microorgan contribut emerg multi drug resist bacteria addit resist antibiot also impos ecotoxicolog effect various anim plant speci presenc fluorin atom fluoroquinolon make high electroneg strong recalcitr less compat microbi degrad mani biolog chemic process invent success implement past decad elimin pollut environ review provid detail overview classif occurr distribut ecotoxicolog effect fluoroquinolon mode action resist mechan detect analysi method remedi strategi also discuss detail | D017753;D024841 | T070;T195;T082;T109 |
36,265,714 | theoret studi pyrolysi mechan decabromodiphenyl ether bde use dft method decabromodiphenyl ether bde bromin flame retard bfr wide appli various consum product due superior perform afford price improv flame resist materi better comprehend pyrolysi behavior bde evolut process main pyrolysi product thermal degrad mechan bde studi use densiti function theori dft method theoret level mcc pvdz thermodynam paramet calcul paper unimolecular degrad domin cleavag ether linkag result high yield hexabromobenzen fission ortho posit c br bond main competit reaction channel system bde h pyrolysi reaction major character debromin lead format consider hbr low bromin diphenyl ether addit hydrogen deriv split ether bond act main competit channel sourc polybromophenol polybromobenzen format polybromin dibenzofuran pbdf deriv cyclize reaction ortho phenyl type radic readili generat ortho posit br atom abstract h radic format polybromin dibenzo p dioxin pbdd involv ortho c coupl reaction polybromophenoxi radic debromin reaction cyclize reaction total yield pbddfs signific increas h involv result present work provid help inform treatment reus bde contain wast plastic use pyrolysi technolog | D005411;D011075 | T120;T131;T109 |
36,265,713 | optim carboxyl graphen oxid c go content polym matrix synthesi character applic studi carboxyl graphen oxid c go embed polysulfon psf membran composit prepar differ wt ie use non solvent induc phase separ nip method ultrafiltr assembl appli remov dye effluent optim c go content polym matrix found influenc factor determin composit membran effici applic various research field membran character term surfac morpholog sem crystallin xrd function group identif ftir water permeabl develop membran analyz observ increas content c go psf membran impos posit impact permeat perform found potenti candid among membran maximum water flux lmh consider higher compar pristin psf membran water flux ie lmh moreov contact angl measur membran also check assess hydrophil psf membran result contact angl also support water permeabl effici correl observ contact angl decreas increas content c go minimum contact angl excel hydrophil shown membran found valu close membran maximum c go content photocatalyt perform membran check uv nm use methylen blue dye dye remov achiev within min reaction time neutral ph condit membran c go content found best membran high pure water flux lmh effici dye reject capabl | D008567;D006108 | T196;T074;T109 |
36,265,712 | insight role microbi communiti lifestyl strategi variat dissolv organ matter molecular composit along effluent domin river urban dramat chang qualiti quantiti dissolv organ matter dom flux river therebi affect divers lifestyl strategi microbi communiti howev relationship dom molecular composit microbi lifestyl strategi effluent domin river poor understood herein investig variat dom structur composit effluent domin river reveal chang alter abund lifestyl strategi microbi communiti result demonstr macromolecular mw kda humic like substanc constitut major compon effluent domin riverin dom also due degrad humic like substanc accumul protein like substanc observ upstream downstream area correspond appar decreas overal aromat abund bacteri actinobacteria eukaryot higher upstream midstream area relat lower downstream area respons bacteri actinobacteria communiti chang dom composit promin compar eukaryot base multivari statist analysi decreas aromat compon mw kda main attribut degrad proteobacteria actinobacteria k strategist result decreas relat abund along river cours protein polysaccharid kda mw kda mw kda easili util firmicut bacteroidet r strategist lead increas relat abund decreas macromolecular humic like substanc increas protein like substanc river microbi communiti shift k strategist r strategist work unveil evolut dom effluent domin river influenc degrad macromolecular humic like substanc rk strategist | D000090422;D064307 | T001;T032;T028;T109 |
36,265,711 | simultan determin anthracen phenanthren use poli alizarin red scarbon past electrod polym base carbon past electrod construct electropolymer alizarin red ar film carbon past electrod cpe surfac electrochem properti poli arscp character cyclic voltammetri cv electrochem imped spectroscopi ei scan electron microscopi sem util electrod character electropolymer cycl construct sensor support electrolyt optim liclo support electrolyt poli arscp abl generat oxid peak anthracen ant phenanthren phe clear defin easili distinguish one anoth oper squar wave voltammetri swv simultan detect linear rang ant phe within detect limit variat peak paramet scan rate investig determin natur electrooxid number electron involv electrod process poli arscp success util detect ant phe differ water sampl obtain result suggest select stabil reproduc modifi electrod | D002244;D010616 | T121;T196;T109 |
36,265,710 | bioaccumul cuo nanomateri rainbow trout influenc exposur rout particl shape bioaccumul potenti spheric rod shape cuo nanomateri nms assess rainbow trout oncorhynchus mykiss expos via water diet follow oecd test guidelin fish expos via diet nms concentr mg cukg day follow day depur water born exposur rod shape cuo nms test mg cul day follow day depur concentr cu determin fish whole bodi deriv biomagnif bioconcentr factor bmf bcf differ tissu sampl investig total cu biodistribut target organ well particl number base bioaccumul cuo nms estim bmf bcf valu threshold concern howev shape rout influenc depur follow dietari exposur higher depur cu fish expos rod shape compar spheric cuo nms higher depur also observ rod shape cuo nms follow dietari exposur compar aqueous one despit much higher dietari exposur concentr rod shape cuo nms similar cu bodi burden reach via water cu found particul form differ tissu although nms low bioaccumul potenti differ distribut elimin pattern cu observ depend exposur rout particl shape care consider relev exposur rout need design bioaccumul experi test nms | D017686;D014874;D049329 | T131;T073;T013 |
36,265,709 | first fulli optim valid spe lc msms method determin new generat neonicotinoid surfac water sampl widespread use new generat neonicotinoid nqs result constant inflow water bodi persist water mechan action similar older compound alreadi ban eu rais concern potenti ecotoxicolog effect inform presenc new nqs aquat environ still spars consequ aquat organ remain most unknown due lack sensit select analyt tool therefor method util solid phase extract liquid chromatographi tandem mass spectrometri spe lc msms develop optim enabl monitor eu approv nqs acetamiprid act sulfoxaflor sfx flupyradifuron flu common nq metabolit chloronicotino acid cna surfac water optim extract natur water sampl respons surfac methodolog rsm use increas ph valu favor higher absolut recoveri ar act sfx flu opposit effect observ cna increas water sampl volum advers effect extract compound optim condit simultan extract compound includ use oasi hlb sorbent ml water sampl ph applic hcooh acetonitril eluent allow obtain ar valu case increas ph valu posit impact extract effect act sfx flu method subject full matrix match valid proven fulli reliabl analysi act sfx flu success isol cna depend matrix composit final method appli analysi nqs surfac water sampl prove sensit select easili adapt tool trace analysi nqs nq associ risk assess aquat ecosystem | D053719;D014874 | T063;T131 |
36,265,708 | adsorpt remov tetracyclin aqueous solut use magnet fe activ carbon prepar cynometra ramiflora fruit wast herein sustain fabric magnet iron oxid nanoadsorb prepar activ carbon ined cynometra ramiflora fruit investig activ carbon obtain phosphor acid treat c ramiflora fruit util synthesi magnet nanocomposit crac fe form nanocomposit porous irregular dens matrix amorph even size spheric nanoparticl visual fesem also contain carbon oxygen iron phosphor element composit ft ir spectrum depict characterist band attribut fe c oh c n cc oh bond vsm xrd result prove crac fe superparamagnet moder degre crystallin high satur magnet valu emug superior surfac area pore size pore volum g nm cm g respect measur bet analysi crac fe nanocomposit indic suitabl use adsorb applic nanocomposit adsorpt tetracyclin maximum remov ppm tc ph crac fe gl min adsorpt tc crac fe confirm monolay sorption ionic interact r follow pseudo second order kinet langmuir isotherm r crac fe show maximum adsorpt capac mgg toward tc antibiot indic potenti treatment antibiot contamin sampl sinc negat g posit h valu obtain test temperatur thermodynam studi adsorpt confirm endotherm spontan feasibl enhanc degre random | D014874;D053761 | T131;T073 |
36,265,707 | comment worldwid basket survey multielement composit white button mushroom agaricus bisporus credibl concentr data report ree question reliabl enough includ databas nutrient mushroom focus comment lanthanid la ce pr nd sm eu gd tb dy ho er tm yb lu togeth sc also call rare earth element ree individu ree similar chemic properti treat group behav similar environ food web howev determin ree food includ edibl mushroom analyt challeng studi siwulski et al concentr report ce nd sm la sm tm other detect method quantif limit sum ce g kg dw nd g kg dw sm g kg dw la g kg dw sm g kg dw tm g kg dw sampl bisporus rang g kg dri weight first visibl characterist larg differ concentr ce nd sm la tm bisporus sampl various wild speci cultiv cyclocyb cylindracea pleurotus ostreatus second correspond oddo harkin order concentr pattern ce nd sm la tm report bisporus sampl pattern clear differ observ wild mushroom two cultiv speci report studi icp oe also low resolut icp ms determin ree direct fungal digest suffer spectral interfer differ type includ effect matrix overcom cours reliabl control analysi ree | D008674;D000364;D028581 | T196;T004 |
36,265,706 | insight manganes ferrit anchor graphen oxid remov cd ii u vi via batch semi batch column potenti antibacteri applic bioaccumul non biodegrad high toxic cd ii u vi water serious concern manganes ferritegraphen oxid gmf nanocomposit synthes character use effici remov cd ii u vi aqueous solut studi x ray diffract xrd x ray photoemiss spectroscopi xps analys respect confirm format gmf adsorpt remov mechan xrd result reveal amorph structur mnfe load onto go surfac xps result suggest c c c ooroh metal oxid respons remov cd ii u vi via electrostat chemic interact accord brunauer emmett teller bet scan electron microscopi sem transmiss electron microscopi tem character analysi gmf high surfac area g spheric shape even distribut kinet data success reproduc pseudo second order non linear model indic complex sorption mechan rate limit maximum langmuir uptak abil gmf cd ii u vi calcul mgg mgg respect use extern magnet power prepar gmf easili separ aqueous solut keep metal ion environment protect agenc standard water six cycl use gmf final gmf nanocomposit demonstr signific promis adsorb remov cd ii u vi actual contamin water sampl antibacteri test expand includ gram negat e coli gram posit aureus better understand gmf bacteri inhibit efficaci | D002104;D014874 | T131;T196 |
36,265,704 | short long term assess pah pcb metal contamin belgian part north sea dredg activ result reloc contamin polycycl aromat hydrocarbon pah polychlorin biphenyl pcbs metal ship channel harbour port marin environ compon may exert negat effect marin ecosystem work contamin associ dredg evalu around dredg spoil dispos site belgian part north sea take account spatial well tempor variat homogen dispers differ contamin observ differ site howev contamin pattern differ dispos site link commerci port result signific higher pah pcb concentr compar concentr environment assess criteria contamin pah exceed criteria belgian part north sea pcbs cb reveal concern high concentr exceed environment assess criteria contrast metal contamin cr ni zn exceed environment limit valu dredg spoil dispos site refer locat | D011078;D014874;D011084 | T131;T109 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.